LifePharm Inc. exemplifies a history of innovation through its premium line of epigenetic products and independent business opportunity. LifePharm’s products address the root cause of anti-aging at the DNA level, evidenced in its proprietary egg bioactive growth factor technology that helps stimulate our own stem cells for cellular regeneration. The company’s epigenetic product line features its flagship product LAMININE, and its patented skin cell regeneration serum LAMIDERM. A global direct selling company, LifePharm operates in over 45 markets worldwide and has had over 500,000 independent business owners and counting.
Medisafe is the leading enterprise patient engagement platform redefining how pharmaceutical companies support patients across the treatment journey. We replace fragmented point solutions with a unified, behavior-driven infrastructure.
By centralizing patient support into one system, we empower pharma teams to deliver a personalized brand experience at portfolio scale.
Our Core Capabilities:
- JITI (Just-In-Time Interventions): Our AI engine predicts patient risk and delivers personalized support to reduce drop-off.
- Omnichannel Coordination: Meeting patients where they are—across mobile, web, voice, and hub services—to ensure a seamless experience.
- Behavioral Data Insights: Leveraging over a decade of real-world data to identify adherence trends and optimize intervention strategies.
- Portfolio-Wide Scaling: One infrastructure to manage engagement across multiple brands, therapies, and global markets.
We don’t just send reminders; we manage the complex variables of the patient journey. By leveraging millions of data points collected over 12 years, Medisafe drives measurable improvements in medication adherence, long-term persistence, and patient retention. Our platform provides the Real-World Evidence (RWE) pharma needs to optimize Time to Fill (TTF), mitigate therapy drop-off, and improve health outcomes at scale.
This is the new model of patient support: predictive, personalized, and built to drive lasting therapy persistence.